Title:
IntenSify: An Open-label Phase I Trial of the CYP3A Inhibitor Cobicistat and the Cytostatics Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma to Evaluate the Combination's Pharmacokinetics, Safety and Efficacy
Phase:
I
Contact:
Katharina Hilse / Kontaktperson
Email-Address:
Katharina.Hilse@med.uni-heidelberg.de
Clinical Investigator:
PD Dr. Nicolas Hohmann
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT05494866
EudraCT-Number:
Keine Registernummer angegeben.